NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
10.41
+0.42 (4.20%)
Mar 23, 2026, 4:00 PM EDT - Market closed
NextCure Market Cap
NextCure has a market cap or net worth of $37.06 million as of March 24, 2026. Its market cap has increased by 85.64% in one year.
Market Cap
37.06M
Enterprise Value
398.87K
1-Year Change
85.64%
Ranking
Category
Stock Price
$10.41
Market Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $37.06M, a decrease of -91.51%. That is a compound annual growth rate of -30.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 35.57M | -28.50% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 39.97M |
| Atara Biotherapeutics | 39.62M |
| Estrella Immunopharma | 38.52M |
| Apollomics | 38.22M |
| CervoMed | 37.22M |
| LeonaBio | 36.95M |
| Veru Inc. | 36.92M |
| NovaBay Pharmaceuticals | 36.74M |